SM
DGX icon

Sciencast Management’s Quest Diagnostics DGX Stock Holding History

Sciencast Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,588
Closed -$1.32M – 298
2025
Q4 		$1.32M Sell
7,588
-12,752
-63% -$2.32M 0.18% 169
2025
Q3 		$3.88M Buy
+20,340
New +$3.61M 0.73% 66
2023
Q3 		– Sell
-6,141
Closed -$858K – 367
2023
Q2 		$858K Buy
+6,141
New +$847K 0.7% 45
2022
Q2 		$1.32M Sell
9,679
-1,112
-10% -$152K 0.3% 119
2022
Q1 		$1.44M Buy
+10,791
New +$1.5M 0.33% 99
2021
Q1 		– Sell
-1,912
Closed -$242K – 530
2020
Q4 		$242K Buy
+1,912
New +$233K 0.05% 390
2019
Q2 		– Sell
-3,000
Closed -$271K – 327
2019
Q1 		$271K Buy
+3,000
New +$260K 0.1% 284
2018
Q4 		– Sell
-15,120
Closed -$1.39M – 254
2018
Q3 		$1.39M Buy
+15,120
New +$1.66M 0.94% 11
2018
Q2 		– Sell
-2,541
Closed -$256K – 283
2018
Q1 		$256K Sell
2,541
-5,754
-69% -$589K 0.13% 268
2017
Q4 		$857K Sell
8,295
-6,813
-45% -$646K 0.46% 78
2017
Q3 		$1.42M Buy
+15,108
New +$1.6M 0.79% 20
2017
Q1 		– Sell
-2,200
Closed -$202K – 359
2016
Q4 		$202K Buy
+2,200
New +$190K 0.28% 173
2016
Q2 		– Sell
-8,700
Closed -$622K – 308
2016
Q1 		$622K Buy
+8,700
New +$583K 0.49% 66

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Sciencast Management's DGX Position: Q1 2026 in Review

Sciencast Management sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 7,588 shares — an estimated $1.32M sold.

Sciencast Management first reported a position in DGX in Q1 2016 and held it in 13 quarters. The position peaked at $3.88M in Q3 2025. 1,069 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Sciencast Management reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Sciencast Management sold 7,588 Quest Diagnostics shares in Q1 2026, an estimated $1.32M.
  • Sciencast Management first reported a position in Quest Diagnostics in Q1 2016 and held it in 13 quarters.
  • Sciencast Management's Quest Diagnostics position peaked at $3.88M in Q3 2025.
  • 1,069 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Sciencast Management's 13F filing for Q1 2026, filed 14 May 2026.